Appeals Court Revives Private Lawsuits Linking Tylenol to Autism

A federal appeals court has given new life to over 500 lawsuits alleging that Tylenol, produced by Kenvue, may be linked to autism. The 2nd U.S. Circuit Court of Appeals in Manhattan determined that a lower court made a mistake by dismissing these cases earlier. This ruling could allow plaintiffs to pursue legal action against the company, potentially impacting how corporations deal with product liability claims in the future. It also highlights the ongoing debate over the safety of medications and the legal avenues available for those who believe they've been adversely affected by pharmaceutical products.